SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-008514
Filing Date
2019-02-08
Accepted
2019-02-08 16:25:52
Documents
1
Period of Report
2019-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6108
  Complete submission text file 0001209191-19-008514.txt   7530
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUNRUN INC. 595 MARKET STREET, 29TH FLOOR SAN FRANCISCO CA 94105
Business Address
Kim Mina (Reporting) CIK: 0001668163 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 19580212